J.P. Morgan Reiterates Overweight Rating on Zoetis Following Prizer Share Exchange
July 08, 2013 at 08:49 AM EDT
In a report published Monday, J.P. Morgan analyst Chris Schott reiterated an Overweight rating and $39.00 price target on Zoetis (NYSE: ZTS ). In the report, J.P. Morgan noted, “Following the Pfizer share exchange making Zoetis a fully publicly-owned company, we wanted to revisit our thesis on the stock. Overall,
